北美卒中诊断市场，按严重程度（中度、重度、轻度）、类型（计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT)、其他）、应用（缺血性卒中、出血性卒中、短暂性脑缺血发作 (TIAS)）、最终用户（医院、诊所、门诊手术中心、家庭医疗保健）、分销渠道（直接招标、第三方分销商、其他）、阶段（术前、术中、术后）、国家（美国、加拿大、墨西哥）、行业趋势和预测到 2028 年
市场分析与洞察：北美中风诊断市场
预计北美中风诊断市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，市场将以 6.6% 的复合年增长率增长，预计到 2028 年将达到 20.9775 亿美元。医疗保健行业研发的增长和医疗保健支出的增加是预计在预测期内推动市场需求的主要驱动因素。相比之下，产品召回正在抑制市场。
当脑部血液供应减少或完全受阻时，就会发生中风，导致脑组织无法获得氧气和营养。目前有多种诊断设备可用于检测中风及其早期症状，例如计算机断层扫描 (CT SCAN)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声等。
中风、心血管和神经系统疾病的发病率不断上升，增加了发展中国家对中风诊断的需求。此外，医疗支出的增加也推动了市场的增长。另一方面，诊断的高成本可能会阻碍市场的增长。市场参与者的存在和新产品的推出为市场提供了机会。然而，缺乏熟练的专业人员可能会给市场带来挑战。
中风诊断市场报告提供了市场份额、新发展、国内和本地市场参与者的影响、新兴收入领域机会分析、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新的详细信息。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美中风诊断市场范围和市场规模
北美中风诊断市场根据严重程度、类型、应用、最终用户、分销渠道和阶段进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据严重程度，北美中风诊断市场分为中度、重度和轻度。预计到 2021 年，中度中风将占据市场主导地位，研发活动也将激增。
- 根据类型，北美中风诊断市场细分为计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT) 和其他。随着政府不断推出提供更先进设备的举措，预计 2021 年计算机断层扫描 (CT 扫描) 领域将占据市场主导地位。
- 根据应用，北美中风诊断市场细分为缺血性中风、出血性中风和短暂性脑缺血发作 (TIAS)。随着主要市场参与者推出的产品不断增加，预计到 2021 年，缺血性中风将占据市场主导地位。
- 根据最终用户，北美中风诊断市场分为医院、家庭医疗保健、门诊手术中心和诊所。预计到 2021 年，医院部门将凭借熟练的专业人员和员工占据市场主导地位。
- 根据分销渠道，北美中风诊断市场分为直接招标、第三方分销商和其他。由于中风患者数量不断增加，预计 2021 年直接招标将占据市场主导地位。
- 根据阶段，北美中风诊断市场分为术前、围手术期和术后。由于产品开发的不断进步，预计 2021 年术前诊断将占据市场主导地位。
中风诊断市场国家级分析
对中风诊断市场进行分析，并根据严重程度、类型、应用、最终用户、分销渠道和阶段提供市场规模信息。
北美中风诊断市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于为提高产品质量而不断增加的研究开发，预计北美地区的中风诊断部门将在 2021 年至 2028 年的预测期内以最高增长率增长。美国预计将引领北美中风诊断市场的增长，由于该国发病率不断上升，预计直接招标部门将占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
新产品开发技术的进步和进步推动了中风诊断市场的增长
中风诊断市场还为您提供每个国家中风诊断行业增长的详细市场分析，包括中风诊断药物销售、中风诊断技术进步的影响以及监管环境的变化及其对中风诊断市场的支持。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和中风诊断市场份额分析
中风诊断市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对中风诊断市场的关注有关。
在北美中风诊断市场开展业务的主要公司有西门子、荷兰皇家飞利浦公司、史赛克、豪洛捷公司、ESAOTE SPA、美创股份公司、深圳安科高科技股份有限公司、Aspect Imaging Ltd、西门子、FONAR Corp、富士胶片控股公司、通用电气公司、ALPINION MEDICAL SYSTEMS 有限公司、TERASON DIVISION TERATECH CORPORATION、Analogic Corporation、锐珂医疗、IMRIS、Deerfield Imaging Inc.、佳能公司、三星、SternMed GmbH 等。
全球各地的公司也发起了许多产品发布和协议，这也加速了中风诊断市场的发展。
例如，
- 2021 年 2 月，荷兰皇家飞利浦公司宣布已成功完成对 BioTelemetry, Inc. 的收购，BioTelemetry 是一家领先的美国远程心脏诊断和监测提供商。此次收购为其产品线添加了新技术可穿戴传感产品
- 2021年9月，三星宣布已完成对HARMAN公司的收购。此次收购增加了公司的产品组合和技术进步
合作、产品发布、业务扩展、奖励和认可、合资企业以及市场参与者的其他策略正在增强公司在中风诊断市场的地位，这也为组织改善其在中风诊断方面的产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA STROKE DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 EPIDEMIOLOGY
6 NORTH AMERICA STROKE DIAGNOSTICS MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATION IN CHINA
6.4 REGULATION IN JAPAN
6.5 REGULATION IN SOUTH AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASE IN THE INCIDENCE OF STROKE
7.1.3 INCREASE IN THE GERIATRIC POPULATION
7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS
7.2.2 INCREASE IN PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE SPENDING
7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY
7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH
7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE
7.4 CHALLENGES
7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO
7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES
8 IMPACT OF COVID-19 ON NORTH AMERICA STROKE DIAGNOSTICS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES
8.5 CONCLUSION
9 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY
9.1 OVERVIEW
9.2 MODERATE
9.3 SEVERE
9.4 MILD
10 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY TYPE
10.1 OVERVIEW
10.2 COMPUTED TOMOGRAPHY (CT SCAN)
10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)
10.4 MAGNETIC RESONANCE IMAGING (MRI)
10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)
10.6 TRANSCRANIAL DOPPLER ULTRASOUND
10.7 VIDEO HEAD IMPULSE TEST (VHIT)
10.8 OTHERS
10.8.1 CAROTID ULTRASOUND
10.8.2 CAROTID ANGIOGRAPHY
10.8.3 ELECTROCARDIOGRAPHY (EKG)
10.8.4 ECHOCARDIOGRAPHY
10.8.5 BLOOD TESTS
10.8.6 NUCLEAR NEUROIMAGING
10.8.7 OTHERS
11 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ISCHEMIC STROKE
11.2.1 THROMBOTIC STROKES
11.2.2 EMBOLIC STROKES
11.3 HEMORRHAGIC STROKE
11.3.1 INTRACEREBRAL HEMORRHAGE
11.3.2 SUBARACHNOID HEMORRHAGE
11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)
12 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 HOME HEALTHCARE
12.6 OTHERS
13 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY STAGE
14.1 OVERVIEW
14.2 PRE OPERATIVE
14.3 PERI OPERATIVE
14.4 POST OPERATIVE
15 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY REGION
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 SIEMENS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 KONINKLIJKE PHILIPS N.V.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GENERAL ELECTRIC COMPANY
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CANON INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 ALPINION MEDICAL SYSTEMS CO., LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 ANALOGIC CORPORATION
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ASPECT IMAGING LTD
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 BPL MEDICAL TECHNOLOGIES
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 CARESTREAM HEALTH
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ESAOTE SPA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 FONAR CORP
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 HOLOGIC, INC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 IMRIS, DEERFIELD IMAGING INC.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 MEDFIELD DIAGNOSTICS AB
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MEDTRON AG
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SAMSUNG
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 SHIMADZU CORPORATION
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.22 SIUI
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 STERNMED GMBH
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 STRYKER
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENTS
18.25 TERASON DIVISION TERATECH CORPORATION
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 44 U.S. STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 45 U.S. STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 U.S. OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 U.S. STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 U.S. ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 U.S. HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 U.S. STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 U.S. STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 U.S. STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 53 CANADA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 54 CANADA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 CANADA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 CANADA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 CANADA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 CANADA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CANADA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CANADA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 CANADA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 62 MEXICO STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 63 MEXICO STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 MEXICO OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 MEXICO STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 MEXICO ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 MEXICO HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 MEXICO STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 MEXICO STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 MEXICO STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA STROKE DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA STROKE DIAGNOSTICS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE NORTH AMERICA STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA STROKE DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA STROKE DIAGNOSTICS MARKET
FIGURE 15 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020
FIGURE 16 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)
FIGURE 17 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE
FIGURE 19 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY TYPE, 2020
FIGURE 20 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 21 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020
FIGURE 24 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 25 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY END USER, 2020
FIGURE 28 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 29 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 32 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 33 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 34 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY STAGE, 2020
FIGURE 36 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
FIGURE 37 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
FIGURE 38 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
FIGURE 39 NORTH AMERICA STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 40 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 41 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 42 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 43 NORTH AMERICA STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)
FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
